Speculation Mounts for Potential FDA Panel Review of Health Risks from Xeljanz, Other JAK Inhibitors
Some believe the FDA is preparing to review the risks and benefits of Xeljanz and similar drugs given recent cancer and heart concerns.…
«
»
Some believe the FDA is preparing to review the risks and benefits of Xeljanz and similar drugs given recent cancer and heart concerns.…
Growing concerns have led to Health Canada announcing a Xeljanz safety review, to determine whether more warnings or actions are needed following studies suggesting the ulcerative colitis drug could increase the risk of cancer and heart attacks.…
New Xeljanz research links the drug to cancer risks, but has not yet led to a warning for users as to which types of cancer they may face.…
Pfizer filed a patent lawsuit over an alleged attempt to create a generic version of Xeljanz shortly after the FDA announced new concerns about the drug’s safety.…
The FDA is weighing new restrictions on Xeljanz, following clinical trial data linking the drug to an increased risk of heart problems and cancer, according to a new report.…
A new FDA warning indicates Xeljanz side effects may increase the risk of heart problems, including heart attacks, and cancer in patients over 50.…
Actemra is being tested in an ongoing clinical trial as a potential treatment for systemic sclerosis, despite growing concerns linking the drug to heart attacks, strokes, and deaths.…
A new study’s findings indicate that while testosterone gels do not thicken artery walls, they also do not appear to significantly improve quality of life for older men.…
AbbVie is pushing to have a number of cases dismissed for not having submitted complete Plaintiff Fact Sheets, but plaintiffs’ attorneys say the company is trying to game the system to get a tactical advantage in future trials.…
A request for the creation of a Testofen testosterone booster MDL has been rejected due to a lack of cases and other factors.…